Abstracts

575 – HIV Reactivation Potential Evaluated by RNA-Seq and DNA Methylation Following LRA Stimulation

Background Latency-reversing agents (LRAs) have shown promise in reactivating HIV reservoir within “shock and kill”approaches. However, molecular mechanisms underlying HIV reactivation within CD4+ T cells as well as predictors of LRA efficacy remain partially unknown. Here, we investigated the transcriptomic and whole genome DNA methylation profile of CD4+ T cells cultured in vitro with or…

546 – Engineering Natural Killer Cells With NKp30-Based Chimeric Antigen Receptors (CARs) to Target HIV

Background Natural killer (NK) cells respond rapidly in early HIV-1 infection. HIV-1 suppression and functional cure strategies can be developed by exploiting the intrinsic function of NK cells in recognizing HIV-infected cells. In our previous work, we profiled the phenotype of human primary NK cells responsive to autologous HIV-1-infected CD4+ T cells in vitro. We…

564 – Ex Vivo Antigen Stimulation Induces HIV-1 Viral Outgrowth From a Pericentromeric Provirus

Background HIV-1 persists despite effective ART due to a reservoir of latently infected CD4+ T cells. Previous studies suggest that intact proviruses integrated in heterochromatic regions are progressively enriched during long-term ART. These proviruses may evade immune recognition due to lower viral gene expression, but their clinical significance upon ART interruption is unclear. Given the…

543 – Immune Dynamics During Reproductive Aging and Substance Use in Women With HIV

Background Estrogen depletion during reproductive aging in women with HIV (WWH) affects HIV reservoir burden and activity. Estrogen inhibits HIV transcription and modulates the immune system. Understanding the impact of hormonal changes on the immune system requires single-cell resolution to capture immune heterogeneity. Substance use disorder, prevalent among WWH, can further impact immune function. Methods…

581.5 – Cyclic Adenosine 3′,5′-Monophosphate Agonist Prevents Establishment and Reversal of HIV Latency

Background Cyclic adenosine 3′,5′-monophosphate (cAMP) is a secondary messenger involved in the regulation of diverse cellular, metabolic, and immunologic processes. Ex vivo and in vitro studies have shown that cAMP levels are elevated in the setting of HIV infection, with T cells from PLWH harboring twice the cAMP level as uninfected individuals. In our previous…

496 – Viral Reservoir Characteristics in Lymphoid Tissues of HIV-1 Elite Controllers

Background Elite controllers maintain undetectable levels of HIV replication in the absence of antiretroviral treatment and are considered as a model for a cure of HIV infection. Recent studies suggest distinct viral reservoir characteristics in blood in such persons, however, viral reservoirs in lymphoid tissues from elite controllers remain largely unexplored.  Methods Paired samples of…

528 – MLN4924 Reduces HIV Transcription, Cell Survival, and HIV Infectivity After Latency Reversal In Vitro

Background Neddylation is essential for post-translational regulation of many cellular processes, including transcription and protein degradation. The NEDD8-activating enzyme inhibitor MLN4924 (MLN) can block degradation of HIV restriction factor APOBEC3G (A3G) in newly infected cells. Here we show that inhibiting neddylation via MLN reduces HIV reactivation from latency after treatment with latency reversing agents (LRAs).…

550 – TLRS Ligands and IL-15 Induce Trained Immunity in CD4 Cells and Limit HIV Infection and Persistence

Background Despite effective HIV suppression by ART, the virus persists in latent reservoirs. Our single-cell data from human and primate studies show that individuals with better HIV control and smaller reservoirs have higher interferon stimulated gene (ISG) expression in CD4+ T cells, linked to greater chromatin accessibility and transcriptional activation. ISG expression could be induced…